Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Liver Transplantation

  Free Subscription


Articles published in Hepatology

Retrieve available abstracts of 54 articles:
HTML format
Text format



Single Articles


    March 2017
  1. AHMED A, Gonzalez SA, Cholankeril G, Perumpail RB, et al
    Treatment of Patients Waitlisted for Liver Transplant with an All-Oral DAAs is a Cost-Effective Treatment Strategy in the United States.
    Hepatology. 2017 Mar 3. doi: 10.1002/hep.29137.
    PubMed     Text format     Abstract available


    February 2017
  2. LEE MW, Raman SS, Asvadi NH, Siripongsakun S, et al
    Radiofrequency Ablation of Hepatocellular Carcinoma as Bridge Therapy to Liver Transplantation: A Ten Year Intention-to-treat Analysis.
    Hepatology. 2017 Feb 7. doi: 10.1002/hep.29098.
    PubMed     Text format     Abstract available


    January 2017
  3. VERNA EC
    The Dynamic Landscape of Liver Transplant in the Era of Effective HCV Therapy.
    Hepatology. 2017 Jan 17. doi: 10.1002/hep.29054.
    PubMed     Text format    


    December 2016
  4. CILLO U, Vitale A, Polacco M, Fasolo E, et al
    Liver transplantation for hepatocellular carcinoma through the lens of transplant benefit.
    Hepatology. 2016 Dec 23. doi: 10.1002/hep.28998.
    PubMed     Text format    


  5. SAVALE L, Sattler C, Coilly A, Conti F, et al
    Long-term outcome in liver transplantation candidates with portopulmonary hypertension.
    Hepatology. 2016 Dec 20. doi: 10.1002/hep.28990.
    PubMed     Text format     Abstract available


  6. GUPTA R, Gupta J
    Strategies to improve survival of patients with intrahepatic cholangiocarcinoma undergoing liver transplantation.
    Hepatology. 2016 Dec 20. doi: 10.1002/hep.28994.
    PubMed     Text format    


  7. SAPISOCHIN G, Bruix J
    In response to: Strategies to improve survival of patients with intrahepatic cholangiocarcinoma undergoing liver transplantation.
    Hepatology. 2016 Dec 20. doi: 10.1002/hep.28993.
    PubMed     Text format    


    November 2016
  8. CHHATWAL J, Samur S, Kues B, Ayer T, et al
    Optimal Timing of Hepatitis C Treatment for Patients on the Liver Transplant Waiting List.
    Hepatology. 2016 Nov 5. doi: 10.1002/hep.28926.
    PubMed     Text format     Abstract available


  9. FLEMMING JA, Kim WR, Brosgart CL, Terrault NA, et al
    Reduction in liver transplant wait-listing in the era of direct-acting antiviral therapy.
    Hepatology. 2016 Nov 5. doi: 10.1002/hep.28923.
    PubMed     Text format     Abstract available


    October 2016
  10. EMOND JC, Griesemer AD
    Tolerance in clinical liver transplantation: The long road ahead.
    Hepatology. 2016 Oct 7. doi: 10.1002/hep.28862.
    PubMed     Text format    


    August 2016
  11. SAPISOCHIN G, Facciuto M, Rubbia-Brandt L, Marti J, et al
    Liver transplantation for "very early" intrahepatic cholangiocarcinoma. international retrospective study supporting a prospective assessment.
    Hepatology. 2016 Aug 2. doi: 10.1002/hep.28744.
    PubMed     Text format     Abstract available


    June 2016
  12. FENG S, Demetris AJ, Spain KM, Kanaparthi S, et al
    Five year histological and serological follow-up of operationally tolerant pediatric liver transplant recipients enrolled in WISP-R.
    Hepatology. 2016 Jun 15. doi: 10.1002/hep.28681.
    PubMed     Text format     Abstract available


    May 2016
  13. YANG CH, Gombar S, Twist CJ, Gratzinger D, et al
    Plasmacytic post-transplant lymphoproliferative disorder with hyperviscosity syndrome in a child after liver transplant.
    Hepatology. 2016 May 26. doi: 10.1002/hep.28657.
    PubMed     Text format    


  14. SAPISOCHIN G, Goldaracena N, Laurence JM, Dib M, et al
    The extended toronto criteria for liver transplantation in patients with hepatocellular carcinoma: A prospective validation study.
    Hepatology. 2016 May 14. doi: 10.1002/hep.28643.
    PubMed     Text format     Abstract available


    March 2016
  15. GUTIERREZ JA, Landaverde C, Wells JT, Poordad F, et al
    Lorcaserin Use in the Management of Morbid Obesity in a Pre-Liver Transplant Patient.
    Hepatology. 2016 Mar 17. doi: 10.1002/hep.28556.
    PubMed     Text format    


  16. BERZIGOTTI A, Saran U, Dufour JF
    Physical activity and liver diseases.
    Hepatology. 2016;63:1026-40.
    PubMed     Text format     Abstract available


    January 2016
  17. TODO S, Yamashita K, Goto R, Zaitsu M, et al
    A Pilot Study of Operational Tolerance with a Regulatory T Cell-Based Cell Therapy in Living Donor Liver Transplantation.
    Hepatology. 2016 Jan 16. doi: 10.1002/hep.28459.
    PubMed     Text format     Abstract available


  18. POORDAD F, Schiff ER, Vierling JM, Landis C, et al
    Daclatasvir With Sofosbuvir and Ribavirin for HCV Infection With Advanced Cirrhosis or Post-Liver Transplant Recurrence.
    Hepatology. 2016 Jan 11. doi: 10.1002/hep.28446.
    PubMed     Text format     Abstract available


  19. LIM KC, Chow PK
    Reply.
    Hepatology. 2016;63:345.
    PubMed     Text format    


  20. DE MATTOS AZ, de Mattos AA
    Model for end-stage liver disease-based allocation system: On the right path, but not there yet.
    Hepatology. 2016;63:344.
    PubMed     Text format    


    December 2015
  21. MAZZAFERRO V
    Squaring the circle of selection and allocation in liver transplantation for HCC: An adaptive approach.
    Hepatology. 2015 Dec 24. doi: 10.1002/hep.28420.
    PubMed     Text format    


    November 2015
  22. FERRER-FABREGA J, Forner A, Liccioni A, Miquel R, et al
    Prospective validation of "ab initio" liver transplantation in hepatocellular carcinoma upon detection of risk factors for recurrence after resection.
    Hepatology. 2015 Nov 13. doi: 10.1002/hep.28339.
    PubMed     Text format     Abstract available


  23. YAO FY, Fidelman N
    Re-accessing the Boundaries of Liver Transplantation for Hepatocellular Carcinoma: Where Do We Stand with Tumor Down-staging?
    Hepatology. 2015 Nov 11. doi: 10.1002/hep.28139.
    PubMed     Text format     Abstract available


  24. CAVALLIN M, Piano S, Angeli P
    Outpatients use of terlipressin for hepatorenal syndrome: Not for all, with caution and a wise liver transplant allocation policy.
    Hepatology. 2015 Nov 2. doi: 10.1002/hep.28324.
    PubMed     Text format    


    October 2015
  25. LAI JC, Dodge JL, Sen S, Covinsky K, et al
    Functional Decline in Patients with Cirrhosis Awaiting Liver Transplantation: Results from the Functional Assessment in Liver Transplantation (FrAILT) Study.
    Hepatology. 2015 Oct 30. doi: 10.1002/hep.28316.
    PubMed     Text format     Abstract available


  26. AGUERO F, Forner A, Manzardo C, Valdivieso A, et al
    HIV Infection Does Not Worsen Prognosis of Liver Transplantation for Hepatocellular Carcinoma.
    Hepatology. 2015 Oct 30. doi: 10.1002/hep.28321.
    PubMed     Text format     Abstract available


  27. STINDT J, Kluge S, Droge C, Keitel V, et al
    Bile Salt Export Pump-reactive Antibodies Form a Polyclonal, Multi-inhibitory Response in Antibody-induced BSEP Deficiency.
    Hepatology. 2015 Oct 30. doi: 10.1002/hep.28311.
    PubMed     Text format     Abstract available


  28. HALAZUN KJ, Patzer RE, Rana AA, Samstein B, et al
    Reply: To PMID 24954365.
    Hepatology. 2015;62:1328-9.
    PubMed     Text format    


  29. YANG T, Lau WY, Huang B, Schwartz M, et al
    Transplantation for hepatocellular carcinoma: more haste, less speed?
    Hepatology. 2015;62:1327-8.
    PubMed     Text format    


    September 2015
  30. PONSIOEN CY, Chapman RW, Chazouilleres O, Hirschfield GM, et al
    Surrogate endpoints for clinical trials in primary sclerosing cholangitis; review and results from an International PSC Study Group consensus process.
    Hepatology. 2015 Sep 29. doi: 10.1002/hep.28256.
    PubMed     Text format     Abstract available


    August 2015
  31. ANTOINE DJ, Sabbisetti VS, Francis B, Jorgensen AL, et al
    Circulating Kidney Injury Molecule 1 Predicts Prognosis and Poor Outcome in Patients With Acetaminophen-Induced Liver Injury.
    Hepatology. 2015;62:591-9.
    PubMed     Text format     Abstract available


    July 2015
  32. BHARADWAJ S, Rivas JM, Jevenn A, Hanouneh I, et al
    Immunonutrition in Patients undergoing Liver Transplantation- Too Premature to Draw Conclusions.
    Hepatology. 2015 Jul 23. doi: 10.1002/hep.28004.
    PubMed     Text format    


  33. BAJAJ JS
    Liver Capsule: Hepatic Encephalopathy.
    Hepatology. 2015 Jul 14. doi: 10.1002/hep.27984.
    PubMed     Text format    


  34. KIRSTEIN MM, Metzler F, Geiger E, Heinrich E, et al
    Prediction of short- and long-term outcome in patients with autoimmune hepatitis.
    Hepatology. 2015 Jul 14. doi: 10.1002/hep.27983.
    PubMed     Text format     Abstract available


  35. GUSTOT T, Fernandez J, Garcia E, Morando F, et al
    Clinical Course of acute-on-chronic liver failure syndrome and effects on prognosis.
    Hepatology. 2015;62:243-52.
    PubMed     Text format     Abstract available


    May 2015
  36. ZAMBAM DE MATTOS A, Alves de Mattos A
    Hepatocellular carcinoma - to resect or to transplant?
    Hepatology. 2015 May 29. doi: 10.1002/hep.27919.
    PubMed     Text format    


  37. MORITA M, Joyce D, Miller C, Fung JJ, et al
    Rejection triggers liver transplant tolerance: Involvements of mesenchyme-mediated Immune Control Mechanisms.
    Hepatology. 2015 May 22. doi: 10.1002/hep.27909.
    PubMed     Text format     Abstract available


    April 2015
  38. BANERJEE S, Wang DS, Kim HJ, Sirlin CB, et al
    A computed tomography radiogenomic biomarker predicts microvascular invasion and clinical outcomes in hepatocellular carcinoma.
    Hepatology. 2015 Apr 30. doi: 10.1002/hep.27877.
    PubMed     Text format     Abstract available


  39. FAITOT F, Allard MA, Pittau G, Ciacio O, et al
    Impact of clinically evident portal hypertension on the course of hepatocellular carcinoma in patients listed for liver transplantation.
    Hepatology. 2015 Apr 24. doi: 10.1002/hep.27864.
    PubMed     Text format     Abstract available


    March 2015
  40. TOSO C, Meeberg G, Hernandez-Alejandro R, Dufour JF, et al
    Total Tumor Volume and Alpha Fetoprotein for selection of transplant candidates with hepatocellular carcinoma: A prospective validation.
    Hepatology. 2015 Mar 17. doi: 10.1002/hep.27787.
    PubMed     Text format     Abstract available


    February 2015
  41. PUNGPAPONG S, Aqel B, Leise M, Werner KT, et al
    Multicenter experience using simeprevir and sofosbuvir with or without ribavirin to treat hepatitis C genotype 1 after liver transplant.
    Hepatology. 2015 Feb 26. doi: 10.1002/hep.27770.
    PubMed     Text format     Abstract available


  42. YAO FY, Mehta N, Flemming J, Dodge J, et al
    Downstaging of Hepatocellular Cancer before Liver Transplant: Long-term Outcome compared to Tumors within Milan Criteria.
    Hepatology. 2015 Feb 18. doi: 10.1002/hep.27752.
    PubMed     Text format     Abstract available


    January 2015
  43. HEIMBACH JK, Hirose R, Stock PG, Schladt DP, et al
    Delayed hepatocellular carcinoma MELD exception score improves disparity in access to liver transplant in the US.
    Hepatology. 2015 Jan 16. doi: 10.1002/hep.27704.
    PubMed     Text format     Abstract available


  44. NEUBERGER J, Mulligan D
    Liver allocation: can we ever get it right and should we ever get it right?
    Hepatology. 2015;61:28-31.
    PubMed     Text format    


  45. THAPAR M, Bonkovsky HL
    Indications for liver transplant and AASLD guidelines.
    Hepatology. 2015;61:408.
    PubMed     Text format    


    December 2014
  46. FORNS X, Charlton M, Denning J, McHutchison JG, et al
    Sofosbuvir compassionate use program for patients with severe recurrent hepatitis C following liver transplantation.
    Hepatology. 2014 Dec 29. doi: 10.1002/hep.27681.
    PubMed     Text format     Abstract available


  47. WANG FS, Fan JG, Zhang Z, Gao B, et al
    The global burden of liver disease: the major impact of China.
    Hepatology. 2014;60:2099-108.
    PubMed     Text format     Abstract available


  48. HALAZUN KJ, Patzer RE, Rana AA, Verna EC, et al
    Standing the test of time: outcomes of a decade of prioritizing patients with hepatocellular carcinoma, results of the UNOS natural geographic experiment.
    Hepatology. 2014;60:1957-62.
    PubMed     Text format     Abstract available


    November 2014
  49. VAN GOLEN RF, Reiniers MJ, van Gulik TM, Heger M, et al
    Organ cooling in liver transplantation and resection: How low should we go?
    Hepatology. 2014 Nov 1. doi: 10.1002/hep.27590.
    PubMed     Text format     Abstract available


  50. GOLDBERG DS, French B, Abt PL, Olthoff K, et al
    Superior survival using living donors and donor-recipient matching using a novel living donor risk index.
    Hepatology. 2014;60:1717-26.
    PubMed     Text format     Abstract available


    October 2014
  51. NAVARRO VJ, Barnhart H, Bonkovsky HL, Davern T, et al
    Liver injury from herbals and dietary supplements in the U.S. Drug-Induced Liver Injury Network.
    Hepatology. 2014;60:1399-408.
    PubMed     Text format     Abstract available


    September 2014
  52. HALAZUN KJ, Rana AA, Patzer RE, Samstein B, et al
    Re: - Waiting time and transplantation for hepatocellular cancer: A balancing between tempus fugit and carpe diem.
    Hepatology. 2014 Sep 11. doi: 10.1002/hep.27435.
    PubMed     Text format    


  53. LAI Q, Lerut J
    Waiting time and transplantation for hepatocellular cancer: A balancing between tempus fugit and carpe diem.
    Hepatology. 2014 Sep 11. doi: 10.1002/hep.27434.
    PubMed     Text format    


    March 2014
  54. LIM KC, Wang VW, Siddiqui FJ, Shi LM, et al
    Cost-effectiveness analysis of liver resection versus transplantation for early hepatocellular carcinoma within the Milan criteria.
    Hepatology. 2014 Mar 18. doi: 10.1002/hep.27135.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Transplantation is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: